What is the significance of Masson bodies in the diagnosis and treatment of cryptogenic organizing pneumonia (COP)?

Masson Bodies in Cryptogenic Organizing Pneumonia

Diagnostic Significance

Masson bodies are the pathognomonic histopathological hallmark of organizing pneumonia, representing buds of granulation tissue (fibroblasts and capillaries) that fill alveolar spaces and indicate organization of a persistent exudate while preserving alveolar architecture. 1

Histopathological Definition

• Masson bodies consist of intraluminal polyps of fibroblastic tissue within alveoli and bronchioles, which are the essential pathological feature distinguishing organizing pneumonia from other interstitial lung diseases 2
• These structures represent loose plugs of connective tissue filling alveolar ducts and alveoli, reflecting an aberrant healing response rather than active infection 3
• The presence of Masson bodies within organizing pneumonia patterns can occur in terminal air spaces and within the organizing pneumonia itself 3

Diagnostic Criteria Integration

According to the 2013 ATS/ERS guidelines, the organizing pneumonia pattern is characterized primarily by this patchy process involving alveolar ducts and alveoli with or without bronchiolar intraluminal polyps 3

For definitive histopathological diagnosis of nonfibrotic COP, the 2020 ATS/JRS/ALAT guidelines require all three features at one biopsy site:

• Cellular interstitial pneumonia (bronchiolocentric, lymphocyte-predominant)
• Cellular bronchiolitis (lymphocyte-predominant) ± organizing pneumonia pattern with Masson bodies
• Poorly formed nonnecrotizing granulomas 3

Biopsy Yield and Sampling Considerations

Transbronchial biopsy can yield diagnostic Masson bodies in the majority of COP patients (7 of 11 cases in one series), making it a reasonable first-line diagnostic approach 1

However, critical caveats exist:

• Open lung biopsy may yield false-negative results due to sampling error, as changes can be focal with very few Masson bodies present 1
• The rapid evolution and changing pattern of the disease contributes to sampling challenges 1
• In one study, 64.7% of diagnoses required open lung biopsy, 29.4% were diagnosed by transbronchial biopsy, and 5.9% by VATS 4

Treatment Implications

Corticosteroid Response

The presence of Masson bodies confirms organizing pneumonia and predicts excellent response to oral corticosteroids in the majority of patients 3, 5

• Typical initial dosing is prednisone ~50 mg/day with prolonged treatment duration of months 6
• In one series, 7 of 12 patients treated with oral corticosteroids improved without any fibrotic changes 4
• Complete recovery occurs in the majority, though relapse is common (reported in up to two-thirds of cases) 3, 2

Prognostic Considerations

A subgroup of patients with organizing pneumonia does not completely resolve despite prolonged treatment, characterized by residual or progressive interstitial fibrosis 3, 5

• Some cases show more marked interstitial inflammation with overlap with cellular NSIP 3
• 5-year survival for cryptogenic OP is 73%, compared to 44% for secondary OP 6
• Spontaneous recovery without treatment is rare but documented 4, 2

Clinical Algorithm

When Masson bodies are identified on biopsy:

1. Exclude secondary causes before diagnosing cryptogenic OP: collagen vascular diseases, infections, malignancies, drug reactions, hypersensitivity pneumonitis 5, 7
2. Correlate with HRCT findings: patchy migratory consolidation in subpleural, peribronchial, or bandlike patterns; reversed halo sign; perilobular opacities 3, 5
3. Confirm subacute presentation: median duration <3 months with cough, dyspnea, ± fever 3, 5
4. Initiate oral corticosteroids once secondary causes excluded 5, 6
5. Monitor for relapse during and after treatment taper 3, 4

Common Pitfalls

• Do not assume absence of Masson bodies excludes COP - focal distribution may result in sampling error even with open lung biopsy 1
• Do not discontinue antibiotics prematurely - COP mimics community-acquired pneumonia, and the diagnosis should be suspected when bilateral airspace disease fails to respond to antimicrobial therapy 6, 8
• Do not overlook drug-induced causes - salicylates, methotrexate, anti-TNF antibodies, and thiopurines can all cause organizing pneumonia with Masson bodies 7